XOMA Co. (NASDAQ:XOMAP) Short Interest Down 37.2% in February

XOMA Co. (NASDAQ:XOMAP) saw a large drop in short interest during the month of February. As of February 27th, there was short interest totaling 774 shares, a drop of 37.2% from the February 12th total of 1,232 shares. Based on an average daily trading volume, of 1,226 shares, the days-to-cover ratio is presently 0.6 days. Based on an average daily trading volume, of 1,226 shares, the days-to-cover ratio is presently 0.6 days.

XOMA Stock Performance

Shares of NASDAQ XOMAP opened at $25.86 on Friday. The company has a 50 day simple moving average of $26.18 and a two-hundred day simple moving average of $26.39. XOMA has a 12 month low of $24.96 and a 12 month high of $30.00.

XOMA Company Profile

XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.

Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.